港股異動 | 三葉草生物-B(2197.HK)續升近7% 股價有望挑戰新高

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

港股異動 | 三葉草生物-B(2197.HK)續升近7% 股價有望挑戰新高

格隆匯 12-10 09:49

格隆匯12月10日丨三葉草生物-B(2197.HK)快速拉昇漲近7%，4日連升30%。現報14.58港元有望挑戰新高價，總市值達168億港元。公司與亞盛醫藥達成臨牀合作，共同推進IAP拮抗劑APG-1387聯合重組人TRAIL-三聚體融合蛋白SCB-313治療腹膜腫瘤的臨牀開發。另外，瑞信考慮到公司新冠候選疫苗SCB-2019近期的銷量，首予其“跑贏大市”評級，目標價16.5港元。

三叶草生物-B(02197.HK)

Relevant Stocks

三叶草生物-B(02197.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

港股異動 | 三葉草生物-B(2197.HK)續升近7% 股價有望挑戰新高

Services

About Us

Agreement Statement